Category - Bayh-Dole Act

autm Bayh-Dole Act Books Business Capitol Hill Congress Government Guest Contributor Guest Contributors innovation intellectual property IPWatchdog Articles Knowledge Ecology International Legislation Licensing march-in rights National Institute of Standards and Technology patent Patents pharmaceuticals technology Technology & Innovation

Knowledge Ecology International Letter Misleads on March-In Rights

“To say, as KEI and different critics do, that the general public is paying for the analysis and improvement of medicine utilizing taxpayer dollars, is at...

Antitrust Bayh-Dole Act Books Business Capitol Hill China Congress drug pricing Government House of Representatives independent inventor independent inventors innovation intellectual property International IP News IPWatchdog Articles Legislation patent Patents pharmaceuticals Senate technology Technology & Innovation

IP and Innovation on Capitol Hill: Week of March 4

This week on Capitol Hill and the Washington D.C. space, the Supreme Courtroom grants the petition in Iancu v. NantKwest; the U.S. Home of Representatives will...

#breakthepatent Access AIDS and Knowledge Bayh-Dole Act bio Books Business Centers for Disease Control and Prevention drug pricing Food and Drug Administration Generics Gilead Sciences Government HIV Initiative for Medicines IP News IPWatchdog Articles march-in rights National Institutes of Health orange book Patents pharmaceuticals PhRMA PrEP Technology & Innovation Truvada

Examining the Truvada #BreakThePatent Debate: Gilead Responds

We consider that one of many biggest limitations to Truvada for PrEP entry in the present day is restricted consciousness of Truvada for PrEP’s position in HIV...